Pembrolizumab - anti-PD-1 antibody Clinical Trials

1 actively recruiting trial across 1 location

Also known as: KEYTRUDA®, Pembrolizumab

Filter by location:

Los Angeles, California1 trial

Study Assessing MTD, Safety, Tolerability, PK and Anti-tumor Effects of LNS8801alone and With Pembrolizumab

Cedars-Sinai Medical Center

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.